- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Congressman Steve Cohen (D-TN) wrote a letter to Drug Czar Gil Kerlikowske on Monday, urging a change to the country’s drug policy with regard to marijuana. In addition to calling the federal policy on medical marijuana “misguided,” Cohen said, “Marijuana does not belong on Schedule I of the Controlled Substances Act.”
There is no evidence that marijuana has the same addictive qualities or damaging consequences as these harder drugs and it should not be treated as such.
Cohen, who has taken FBI Director Robert Mueller to task over the federal government’s policy, called for compassion in his letter to Kerlikowske:
We should not deny the thousands of Americans who rely on marijuana to treat the effects of AIDS, cancer, glaucoma, multiple sclerosis, and other illnesses the benefits that marijuana provides.
Cohen also described a personal experience he had with medical marijuana:
I have personally witnessed a close friend who was suffering in the last days of pancreatic cancer benefit tremendously from smoking marijuana. It increased his appetite, eased his pain, and allowed him to smile. It allowed him to deal with death with a little more dignity.
Fortunately, there is a bill currently in Congress that would reclassify medical marijuana. Americans for Safe Access (ASA) is mobilizing people to urge their Members of Congress to pass HR 1983, a bill that would reclassify marijuana to Schedule III and allow states to pass their own laws.
ASA has also taken the Obama Administration to court over its refusal to reclassify marijuana. After a 2002 petition filed by the Coalition for Rescheduling Cannabis (CRC) was denied earlier this year, ASA and the CRC filed an appeal in the D.C. Circuit. Advocates are hopeful that either Congress or the courts will push the federal government to address medical marijuana with a sensible public health policy.